Secondary Hyperparathyroidism (SHPT)
Also known as: Secondary hyperparathyroidism (HPT) / Secondary Hyperparathyroidism / Hyperparathyroidism secondary / Secondary hyperparathyroidism (disorder) / Hyperparathyroidism, Secondary
|A vitamin D analogue used for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure, as well as some types of rickets and osteomalacia.
|An active metabolite of vitamin D used to treat hyperparathyroidism as well as to combat hypocalcemia in dialysis patients.
|An active metabolite of vitamin D that is used to treat hyperparathyroidism and is also used in dialysis patients to combat hypocalcemia.
|A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in chronic kidney disease and hypercalcemia in parathyroid carcinoma.
|A synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis.
|A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in patients with chronic kidney disease who require hemodialysis.
|A vitamin D analog used to treat hyperparathyroidism associated with stage 3 or greater chronic kidney disease.